Skip to content

Biodesix, Inc. BDSX Other current assets

Other current assets at other companies

NeoGenomics logo
NeoGenomicsNEO
GeneDx Holdings logo
GeneDx HoldingsWGS
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s other current assets?
Biodesix, Inc. (BDSX) reported other current assets of $5.84M in Q1 2026.
How has Biodesix, Inc.'s other current assets changed year-over-year?
Biodesix, Inc.'s other current assets increased by 33.3% year-over-year, from $4.38M to $5.84M.
What is the long-term trend for Biodesix, Inc.'s other current assets?
Over 5 years (2020 to 2025), Biodesix, Inc.'s other current assets has grown at a -12.4% compound annual growth rate (CAGR), from $8.71M to $4.5M.